L308-1219 Screening compound: N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

L308-1219 Screening compound: N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide
L308-1219 Screening compound: N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L308-1219
N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L308-1219

Molecular Formula

C21H28N4O5S (C21 H28 N4 O5 S)

Compound Name

N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

IUPAC name

N-cyclohexyl-3-{3-[4-(morpholine-4-sulfonyl)phenyl]-124-oxadiazol-5-yl}propanamide

SMILES

O=C(CCc1nc(-c(cc2)ccc2S(N2CCOCC2)(=O)=O)no1)NC1CCCCC1

InChI

InChI=1S/C21H28N4O5S/c26-19(22-17-4-2-1-3-5-17)10-11-20-23-21(24-30-20)16-6-8-18(9-7-16)31(27,28)25-12-14-29-15-13-25/h6-9,17H,1-5,10-15H2,(H,22,26)

InChI Key

FNFCZKGVDNTUOH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243861

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.54

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.856

Distribution Coefficient, logD

2.856

Water Solubility, LogSw

-3.49

Polar Surface Area

95.126

Acid Dissociation Constant (pKa)

15.48

Base Dissociation Constant (pKb)

4.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.10

L308-1219 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Antibacterial Compounds Library (13827 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Immune system
  • animal
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L308-1219 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L308-1219?
Check Price and Availability of L308-1219, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L308-1219 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L308-1219
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L308-1219
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L308-1219 available by request